Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)

Part of paid clinical trials in Fort Worth, Texas.

Sponsor
University of North Texas Health Science Center
Study ID
NCT03437694
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Medication optimization intervention — OTHER
    Pharmacists will engage participants in medication therapy management either with access to the medical records (intervention) or without access (control).

Study Details

This is a clinical trial. The purpose of this clinical trial is to see if study participants have better health outcomes if their pharmacist has access to their medical records. The study will take place primarily in Fort Worth and Dallas, Texas. The trial will enroll adult, African-Americans with HIV. Study participants must also have either diabetes, high blood pressure or they may have both. Study participants will agree to have their medical records from all of their health providers released to UNTHSC. UNTHSC will provide the study pharmacist the medical records for half of the participants. Using the medical records, the study pharmacist will provide 'enhanced' patient counseling services to half of the participants. This enhanced service is called 'medication optimization'. For half of the participants that the study pharmacist does not see the medical records, they will receive usual and customary patient counseling. Not seeing the medical records is considered standard of care. In both groups, the counseling frequency will be based on the participant's needs but the study pharmacist will contact every participant to check on them at least every 90 days. These visits will happen for 2 years. The two groups will be compared to see if those participants having medical information supported medication optimization have better health than those getting routine, the standard of care medication optimization.

Key Dates

Start date
Aug 3, 2018
Status verified
Jul 2025
Primary completion
Jan 31, 2024
Completion
Feb 27, 2025

Study Design

Enrollment
129 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Medication Optimization Intervention
    This group will represent those participants whose medical records have been provided to the pharmacist.
  • Active Comparator: Medication Optimization Control
    This group will represent those participants whose medical records have not been provided to the pharmacist.

Primary Outcome Measure

Average A1c [ Time Frame: Through study completion, up to 3 years ]

Locations (2)

FacilityCityStateZIPSite coordinators
Crystal HodgeFort WorthTexas76107-
University of North Texas Health Science CenterFort WorthTexas76107-

Find similar trials in Fort Worth, TX

By condition
Type 2 diabetesHIVHypertension (high blood pressure)
By specialty
EndocrinologyMetabolic healthWeight lossInfectious diseaseCardiologyHeart disease
By research site
Crystal Hodge· Fort Worth, TXUniversity of North Texas Health Science Center· Fort Worth, TX

Related Studies